Improving medication safety during transitions from hospitals to nursing facilities
Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities
This study is looking at ways to make it easier and safer for patients moving from the hospital to a nursing facility by improving how their medications are managed, so they can avoid problems and stay healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10896943 on NIH RePORTER |
What this research studies
This research focuses on enhancing the transition process for patients moving from hospitals to skilled nursing facilities (SNFs) to prevent medication-related issues. It aims to address the common discrepancies that occur during this transition, which can lead to complications and hospital readmissions. The approach involves a structured communication process, known as the Pharmacy Integrated Transitions (PIT) program, which includes a 'warm-handoff' between hospital and SNF clinical teams, engaging patients and their families in the process. By improving medication reconciliation and coordination, the research seeks to ensure safer transitions for vulnerable patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients transitioning from acute care hospitals to skilled nursing facilities, particularly those with complex medication regimens.
Not a fit: Patients who are not transitioning to skilled nursing facilities or those with stable medication regimens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce medication errors and improve patient outcomes during transitions to skilled nursing facilities.
How similar studies have performed: Previous collaborative efforts in Washington State have shown promise in improving care transitions and reducing medication-related problems, indicating that this approach has potential for success.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Davidson, Giana — University of Washington
- Study coordinator: Davidson, Giana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.